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Abstract
Background: Primary squamous cell carcinoma of the thyroid is an extremely rare neoplasm, with
less than 50 cases reported in the world literature. The prognosis is poor with a median survival
of less than six months. The death is usually secondary to progression of local disease as distant
metastases are rare.
Case reports: Three cases, two males and one female presenting with sudden increase in the size
of long standing thyroid swellings and associated pressure effects on the aero-digestive tract are
reported. Exhaustive clinical, endoscopic, and radiological examinations did not reveal any primary
site of squamous-cell carcinoma as the likely source of the metastases, or of any contiguous spread
from neighboring structures. Two cases were managed by combined modality therapy including
curative surgery with radiotherapy and one by radiotherapy alone.
Conclusion: Primary squamous cell carcinoma is a rare malignancy with a poor outcome inspite
of combined modality therapy. Out of three reported cases, two succumbed to their disease within
less than one year. Aggressive surgery in the form of curative resection along with adjuvant
radiotherapy is recommended, the tumor being chemo resistant.
Background
Primary squamous cell carcinoma (SCC) of thyroid gland
is an extremely rare neoplasm, representing less than 1%
of all primary thyroid malignancies [1]. The evaluation of
this disease involves a combination of endoscopy and
radiographic examination by computerized tomography
to exclude SCC that has spread from adjacent upper aero-
digestive tract sites, as well as metastasis from distant sites
such as lungs, kidneys or gastrointestinal tract [2]. Primary
SCC of thyroid affects older patients (5th to 6th decade)
with a long-standing goitre and the presentation is usually
as a sudden increase in size of a chronic neck mass, with
or without cervical lymphadenopathy. Other symptoms
include dysphagia, dyspnoea and hoarseness of voice due
to infiltration of adjacent structures. At the time of diagno-
sis, these tumors are usually locally advanced with inva-
sion into the trachea, oesophagus or major vessels.
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Case reports
Case 1
A 50-year-old lady presented with a rapid increase in the
size of a thyroid swelling of 20 years duration associated
with pain, fever, dysphagia, hoarseness of voice and stri-
dor. She was toxic, pale (Hb = 7 gm%) and tachypnoic
with engorged neck veins. There was a 5 × 3 cm ulcero-
proliferative growth in the region of the thyroid(fig. 1).
Indirect laryngoscopy was suggestive of a paralyzed left
cord and fine needle aspiration cytology (FNAC) revealed
pus with necrotic debris consistent with diagnosis of thy-
roid abscess. Ultrasonography and CECT(contrast
enhanced computed tomography) neck were however
suspicious of thyroid malignancy with cystic degeneration
and pressure effects on trachea (fig. 2). Chest radiograph/
ultrasound abdomen and thyroid function tests were nor-
mal. In view of the pressure symptoms and suspicion of
malignancy, the patient underwent surgery in the form of
left hemi-thyroidectomy with drainage of abscess and cen-
tral neck dissection.
Gross examination of the specimen revealed a weight of
35 grams with a nodule measuring 3 × 3 × 2 cm with a
thin capsule. The cut surface was grey-white with focal
areas of purulent material. On histopathological examina-
tion polygonal tumor cells were seen adjoining an area of
lymphocytic thyroiditis and focal necrosis. Squamous dif-
ferentiation of tumor cells was seen as cellular keratiniza-
tion and keratin pearl formation. There was marked
pleomorphism of nuclei and occasional abnormal mitosis
and no evidence of associated follicular adenoma/carci-
noma or papillary carcinoma. The level VI lymph nodes
showed squamous cells with necrotic changes. Staining
with mucicarmine and PAS (periodic shiff test) were neg-
ative. Immunohistochemistry showed pancytokeratin
positivity while thyroglobulin and calcitonin were nega-
tive. Histopathological diagnosis was squamous cell carci-
noma of thyroid with metastasis to pre and para tracheal
lymph nodes (fig. 3).
The postoperative period was stormy but she eventually
recovered and was discharged on the tenth day. She
received adjuvant radiotherapy (50 Gy) but succumbed to
her disease within 7 months of her surgery.
Case 2
A 60-year-old gentleman presented to the surgical emer-
gency with difficulty in breathing, hoarseness of voice and
stridor. He had undergone subtotal thyroidectomy for a
non-toxic goitre 25 years previously at a remote district
hospital. Emergency tracheostomy had to be done since
he was in respiratory distress. There was a 5 × 6 cm, hard,
ulceroproliferative growth in the midline with hard, pal-
pable lymph nodes in the pre and paratracheal region (fig.
4). CECT head and neck revealed a thyroid growth infil-
trating in to the larynx with metastatic (level-II, III, VI) cer-
vical lymph nodes. No other site of malignancy could be
detected inspite of an exhaustive battery of investigations
including CECT (chest) and panendoscopy. Fine needle
aspiration cytology from the swelling revealed a poorly
differentiated squamous cell carcinoma of thyroid.
Surgery in the form of wide local excision including the
skin around the swelling and ulcer, total thyroidectomy
with laryngectomy and resection of the anterior wall of
pharynx was performed. Modified radical neck dissection
(Type-I i.e. preserving internal jugular vein on left side)
and radical neck dissection (on right side) along with cen-
tral neck dissection were performed. In view of the skin
and tissue loss the reconstruction was done using bilateral
deltopectoral (DP) fasciocutaneous flaps. Histopatholog-
ical examination of the specimen revealed squamous cell
carcinoma of thyroid with anaplastic changes and clear
margins. Postoperative period was stormy but the patient
eventually recovered and received adjuvant radiotherapy
(50 Gy) in fractionated doses. He however died of an
acute attack of myocardial infarction nearly one year after
his surgery.
Case 3
A 58-year-old-male from an endemic zone of goiter (sub-
Himalayan belt of north India) presented with a recurrent
thyroid swelling which had been increasing in size rapidly
Case 1: Clinical picture showing the ulcero-proliferative  growth in the region of thyroid Figure 1
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for the past three months(fig. 5). He had undergone sub-
total thyroidectomy for goiter, 15 years back. He was in
distress with engorged neck veins and stridor along with a
midline 5 × 5 cm ulcero-proliferative growth along and
left cervical lymphadenopthy (levels-II, III, VI). The fine
needle aspiration cytology of the swelling and the edge
biopsy from the ulcer confirmed the diagnosis of squa-
mous cell carcinoma of thyroid. No other site of the squa-
mous cell carcinoma could be detected inspite of an
exhaustive clinical and radiological/endoscopic evalua-
tion. The patient was managed by curative wide local exci-
sion, including total thyroidectomy and left sided radical
neck dissection. He received adjuvant radiotherapy (50
Gy in fractionated doses) and follow up of one year is sat-
isfactory.
Discussion
Primary SCC of the thyroid is an extremely rare and
aggressive neoplasm. The World Health Organization
(WHO) definition of the neoplasm states;
"Tumor comprising entirely of cells showing so-called intercel-
lular bridges and/or forming keratin"[1]. It may be associated
Case 1: The Photomicrograph with nests of pleomorphic cells with abundant eosinophillic cytoplasm and multifocal areas of  keratin formation along with intercellular bridging(hematoxylin-eosin 400×) Figure 3
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Case 1: Computed tomography showing the growth with  pressure on the trachea Figure 2
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with other malignancies of thyroid especially papillary carci-
noma [2-6]. The usual presentation is in the form of rapidly
enlarging mass in older patients behaving like anaplastic carci-
noma [6-9]".
Fine needle aspiration cytology (FNAC) confirms the
diagnosis of SCC but it is mandatory to exclude SCC that
has spread from adjacent upper aero digestive tract sites,
as well as metastasis from distant sites, such as the lung,
kidney, or gastrointestinal tract [2,3,6-9]. The evaluation
therefore usually involves a combination of endoscopy
and radiographic examination by computed tomography
to rule out the neighbouring or metastatic carcinoma [1,9-
12].
The aetiology of this condition is not clear, but hypothe-
ses include the "metaplasia theory" (squamous metapla-
sia of underlying thyroid disease) and "embryonic-nest
theory" (squamous cells originating from remnant ulti-
mobranchial duct or thyroglossal duct) as a result of meta-
plasia of papillary or follicular cells of the thyroid or from
the embryonic remnants with metaplasia of follicular epi-
thelium (thyroglobulin positive variety) [Follicular varia-
ble]. It may also arise as de – novo appearance from the
follicular cells without metaplasia (thyroglobulin nega-
tive variety), which has worse prognosis [2-4].
The histopathological diagnosis requires microscopic
identification of keratin or intercellular bridge structures
[3]. Treatment with surgery, radiation, or chemotherapy
alone is usually inadequate. The best survival rates have
been achieved with aggressive surgical resection of the dis-
ease followed by postoperative radiation therapy [5].
Adjuvant radiation therapy in the doses ranging from 40
to 55 Gy are recommended [6]. Although SCC of the thy-
roid is considered to be radio resistant and unresponsive
Case 2: Clinical picture showing the recurrent ulcero-proliferative growth of thyroid. The tracheostomy tube is in situ Figure 4
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Case 3: Clinical picture showing the recurrent growth, the scar of old surgery is also visible Figure 5
Case 3: Clinical picture showing the recurrent growth, the scar of old surgery is also visible.Publish with BioMed Central    and   every 
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to chemotherapy, there have been a few cases where com-
plete excision and post-operative radiation have been cur-
ative [7-12]. Death is usually secondary to progression of
local disease although some cases have been found to
have distant metastases at autopsy [11].
Conclusion
Primary squamous cell carcinoma of thyroid is a rare and
aggressive tumor with dismal outcome. The diagnosis
may come as an operative or histological surprise.
Although the outcome is dismal, aggressive surgery along
with adjuvant radiotherapy are recommended in the man-
agement of this rare and aggressive cancer for optimum
outcome.
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